Advertisement

FDA Approves Return of Primatene Mist Asthma Inhaler

FDA Approves Return of Primatene Mist Asthma Inhaler

Created: November 08, 2018 04:16 PM

LINDA A. JOHNSON, AP Medical Writer

Advertisement – Content Continues Below

TRENTON, N.J. (AP) - A new version of the once-popular asthma inhaler Primatene Mist will soon return to U.S. stores.

The Food and Drug Administration approved the over-the-counter aerosol inhaler late Wednesday. It's for temporary relief of mild, intermittent asthma symptoms in people ages 12 and up.

The original Primatene Mist was pulled from store shelves seven years ago because the inhaler's ozone-depleting propellant had been banned. That version had been marketed for half a century, including in memorable TV ads .

The new product from Amphastar Pharmaceuticals uses a safer propellant. The inhaler will cost about $25 and should be available by the end of the year.

The FDA said in a statement that the inhaler should not be substituted for prescription treatments or used by people with severe asthma.

Copyright 2018 The Associated Press. All rights reserved.

Advertisement
Advertisement
Relay Media Amp

Council Derails Historic Designation for LS&M Railroad

Zup's Loss Reaches Beyond Immediate Community

Authorities Seeking Help in Hinckley Robbery

Black Water Lounge to Temporarily Close During Superior St. Reconstruction

Minnesota Man's Father Among the Missing in California Fires

Glensheen, Bentleyville Nominated for National Awards

Advertisement
Advertisement
Advertisement